Large gap with delayed quotes
Analysis date: 11.11.2025
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 05.09.2025.
Interest
Strong
Strong
Three stars since 19.09.2025.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 12.09.2025 at a price of 689.80.
Evaluation
Overvalued
Overvalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 05.09.2025.
4wk Rel Perf
6.33%
6.33%
The four-week dividend-adjusted overperformance versus STOXX600 is 6.33%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 05.09.2025.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.92%.
Mkt Cap in $bn
392.05
392.05
With a market capitalization >$8bn, ASML HOLDING is considered a large-cap stock.
G/PE Ratio
0.80
0.80
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
27.06
27.06
The estimated PE is for the year 2027.
LT Growth
20.65%
20.65%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
34
34
Over the last seven weeks, an average of 34 analysts provided earnings per share estimates.
Dividend Yield
0.89%
0.89%
The twelve month estimated dividend yield represents 24.07% of earnings forecasts.
Beta
154
154
For 1% of index variation, the stock varies on average by 1.54%.
Correlation
0.57
0.57
57.03% of stock movements are explained by index variations.
Value at Risk
211.44
211.44
The value at risk is estimated at EUR 211.44. The risk is therefore 23.84%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
02.01.2002
02.01.2002